Molecular and clinical profiling of gastroenteropancreatic (GEP) neuroendocrine tumors (NETs): An analysis of the Oncology Research Information Exchange Network database. This is an ASCO Meeting ...
A phase III study of combination therapy with everolimus plus lanreotide versus everolimus monotherapy for unresectable or recurrent gastroenteropancreatic neuroendocrine tumor (JCOG1901, STARTER-NET) ...
After a review by the neuroendocrine multidisciplinary ... further surgical intervention to remove his primary small-bowel carcinoid tumor. Carcinoid tumors commonly originate in the ...